These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 514359)

  • 21. Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase.
    Guengerich FP
    Biochemistry; 1978 Aug; 17(17):3633-9. PubMed ID: 28754
    [No Abstract]   [Full Text] [Related]  

  • 22. On the role of the axial ligand in heme proteins: a theoretical study.
    Rydberg P; Sigfridsson E; Ryde U
    J Biol Inorg Chem; 2004 Mar; 9(2):203-23. PubMed ID: 14727167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
    Boerma JS; Vermeulen NP; Commandeur JN
    Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STUDIES ON THE OXIDATION--REDUCTION POTENTIALS OF HEME PROTEINS. 3. THE EFFECT OF BROMTHYMOL BLUE ON THE OXIDATION--REDUCTION POTENTIALS OF HUMAN HEMOGLOBIN.
    ANTONINI E; WYMAN J; BRUNORI M; FANELLI R
    Biochim Biophys Acta; 1965 Jan; 94():188-93. PubMed ID: 14273399
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudomonas putida cytochrome P-450: ligands of the substrate-free and substrate-bound states of the ferric hemoprotein.
    Peterson JA; Griffin BW
    Drug Metab Dispos; 1973; 1(1):14-20. PubMed ID: 4149376
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of ferric haemoproteins by tetrahydropterins: a kinetic study.
    Capeillere-Blandin C; Mathieu D; Mansuy D
    Biochem J; 2005 Dec; 392(Pt 3):583-7. PubMed ID: 16050807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygenation of hydrocarbons by cytochrome P-450 model compounds: modification of reactivity by axial ligands.
    Collman JP; Kodadek T; Raybuck SA; Meunier B
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):7039-41. PubMed ID: 6580626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by cycloheximide of degradation of cytochrome P-450 in primary cultures of adult rat liver parenchymal cells and in vivo.
    Guzelian PS; Barwick JL
    Biochem J; 1979 Jun; 180(3):621-30. PubMed ID: 486136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 30. Alterations in hepatic microsomal cytochrome P-450 hemeproteins in diabetic rats.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):329-37. PubMed ID: 6768119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the microsomal electron-transport system of anaerobically grown yeast. I. Intracellular localization and characterization.
    Yoshida Y; Kumaoka H; Sato R
    J Biochem; 1974 Jun; 75(6):1201-10. PubMed ID: 4154327
    [No Abstract]   [Full Text] [Related]  

  • 32. Bio-organic chemistry and cytochrome P-450-dependent catalysis.
    Sligar SG; Gelb MH; Heimbrook DC
    Xenobiotica; 1984; 14(1-2):63-86. PubMed ID: 6372267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analyses of the oxygen activation of heme-containing oxygenases by heme-substitution technics].
    Makino R
    Seikagaku; 1987 Apr; 59(4):191-204. PubMed ID: 3302064
    [No Abstract]   [Full Text] [Related]  

  • 34. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
    Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
    Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mercaptide-anion as a trans-ligand in oxycytochrome P450.
    Budyka MF; Khenkin AM; Shteinman AA
    Biochem Biophys Res Commun; 1981 Jul; 101(2):615-22. PubMed ID: 7306099
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of the axial ligand on substrate sulfoxidation mediated by iron(IV)-oxo porphyrin cation radical oxidants.
    Kumar D; Sastry GN; de Visser SP
    Chemistry; 2011 May; 17(22):6196-205. PubMed ID: 21469227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STUDIES ON THE OXIDATION-REDUCTION POTENTIALS OF HEME PROTEINS. IV. THE KINETICS OF OXIDATION OF HEMOGLOBIN AND MYOGLOBIN BY FERRICYANIDE.
    ANTONINI E; BRUNORI M; WYMAN J
    Biochemistry; 1965 Mar; 4():545-51. PubMed ID: 14311627
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride.
    Persson JO; Terelius Y; Ingelman-Sundberg M
    Xenobiotica; 1990 Sep; 20(9):887-900. PubMed ID: 2122605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resonance Raman studies of hepatic microsomal cytochromes P-450: evidence for strong pi basicity of the fifth ligand in the reduced and carbonyl complex forms.
    Ozaki Y; Kitagawa T; Kyogoku Y; Imai Y; Hashimoto-Yutsudo C; Sato R
    Biochemistry; 1978 Dec; 17(26):5826-31. PubMed ID: 728439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupling of spin, substrate, and redox equilibria in cytochrome P450.
    Sligar SG
    Biochemistry; 1976 Nov; 15(24):5399-406. PubMed ID: 187215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.